VERU logo

Veru (VERU)

Profile

Full Name

Veru Inc.

Ticker Symbol

VERU

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 11, 1999

Indexes

Not included

Website

http://verupharma.com

Employees

210

Key Details

Price

$0.50(-3.56%)

Market cap

Last Dividend

$0.07

TTM Dividend yield

-

Annual revenue

$16.89M(+3.62% YoY)

Annual EPS

-$0.28(+74.55% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.50
    VERU price is $0.50

    30-Day Relative Volume

    0.65
    VERU 30-day relative volume is 0.65

    Price Performance

    Price Today change

    -3.56%
    VERU price is down -3.56% today

    Price YTD change

    -22.54%
    VERU price is down -22.54% since January 1st

    Price 1-year change

    -63.25%
    VERU price is down -63.25% year-on-year

    Price 3-year change

    -93.82%
    VERU price is down -93.82% over the past 3 years

    Price Range

    Price All-time high

    $24.57
    VERU price is currently -97.95% below its historical high of $24.57

    Price 3-year low

    $0.36
    VERU price is currently +39.86% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $73.70M
    VERU market capitalization is $73.70 million

    Market cap 3-year change

    -88.71%
    VERU market capitalization is down -88.71% over the past 3 years

    Market cap All-time high

    $1.89B
    VERU market capitalization is currently -96.10% below its historical high of $1.89 billion

    Market cap sector rank

    42.29%
    VERU market capitalization is higher than 42.29% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    VERU {parameterFullLabel} has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +82.83%
    VERU shares outstanding is up +82.83% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.27
    VERU beta is 1.27

    200-day SMA

    $0.70
    VERU price is currently -28.09% below its 200-day simple moving average

    50-day SMA

    $0.53
    VERU price is currently -4.19% below its 50-day simple moving average

    RSI

    44.44
    VERU 14-day relative strength index is 44.44

    Volume

    0.65
    VERU 30-day relative volume is 0.65

    ATR

    $0.04
    VERU average true range is $0.04

    10-day Historical Volatility

    52.79%
    VERU 10-day historical volatility is 52.79%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.07
    VERU last dividend was $0.07 per share, with an ex-dividend date of April 28, 2014

    Next Dividend

    -
    VERU next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    VERU annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    VERU annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    VERU annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    VERU annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    VERU annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    VERU annual dividend yield is unknown

    Other

    Payout ratio

    -
    VERU annual payout ratio value is unknown

    Dividends paid

    -
    VERU annual dividends paid value is unknown

    Free cash flow

    -$21.84M
    VERU annual free cash flow is -$21.84 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $16.89M
    VERU annual revenue is $16.89 million

    Revenue Analysts estimate

    -
    VERU annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +3.62%
    VERU annual revenue is up +3.62% year-on-year

    Revenue Sector rank

    32.54%
    VERU annual revenue is higher than 32.54% of companies in Healthcare sector

    EPS

    EPS

    -$0.28
    VERU annual earnings per share is -$0.28

    EPS Analysts estimate

    -$0.22
    VERU annual earnings per share is currently +27.27% higher than the consensus analysts' forecast

    EPS 1-year change

    +74.55%
    VERU annual earnings per share is up +74.55% year-on-year

    EPS Sector rank

    74.73%
    VERU annual earnings per share is higher than 74.73% of companies in Healthcare sector

    Profit

    Gross profit

    $5.85M
    VERU annual gross profit is $5.85 million

    Gross margin

    34.67%
    VERU annual gross profit margin is 34.67%

    Operating profit

    -$38.14M
    VERU annual operating income is -$38.14 million

    Operating margin

    -225.85%
    VERU annual operating profit margin is -225.85%

    Net income

    -$37.80M
    VERU annual net profit is -$37.80 million

    Net margin

    -223.86%
    VERU annual net profit margin is -223.86%

    Expenses

    Total expenses

    $55.02M
    VERU annual total expenses is $55.02 million

    Operating expenses

    $43.99M
    VERU annual total operating expenses is $43.99 million

    Cost of goods sold

    $11.03M
    VERU annual cost of goods sold is $11.03 million

    Selling, general & administrative expenses

    $31.18M
    VERU annual SGA is $31.18 million

    Depreciation and amortization

    $268.20K
    VERU annual depreciation & amortization is $268.20 thousand

    Interest expense

    $607.50K
    VERU annual interest expense is $607.50 thousand

    Income tax

    $725.10K
    VERU annual income tax is $725.10 thousand

    EBIT & EBITDA

    EBIT

    -$36.47M
    VERU annual earnings before interest & taxes is -$36.47 million

    EBITDA

    -$36.20M
    VERU annual EBITDA is -$36.20 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $60.42M
    VERU annual total assets is $60.42 million

    Non current assets

    $25.20M
    VERU annual long term assets is $25.20 million

    Current assets

    $35.22M
    VERU annual total current assets is $35.22 million

    Cash and cash equivalents

    $24.92M
    VERU annual cash & cash equivalents is $24.92 million

    Accounts receivable

    $3.96M
    VERU annual accounts receivable is $3.96 million

    Inventory

    $4.14M
    VERU annual inventory is $4.14 million

    Liabilities

    Total liabilities

    $28.10M
    VERU annual total liabilities is $28.10 million

    Long term liabilities

    $16.23M
    VERU annual total long term liabilities is $16.23 million

    Current liabilities

    $11.87M
    VERU annual total current liabilities is $11.87 million

    Accounts payable

    $3.04M
    VERU annual accounts payable is $3.04 million

    Debt

    Total debt

    $13.86M
    VERU annual total debt is $13.86 million

    Total debt 1-year change

    -3.76%
    VERU annual total debt is down -3.76% year-on-year

    Long term debt

    $11.77M
    VERU annual long term debt is $11.77 million

    Short term debt

    $2.09M
    VERU annual short term debt is $2.09 million

    Equity & Capital

    Shareholders equity

    $32.32M
    VERU annual stockholders equity is $32.32 million

    Book value

    $32.32M
    VERU annual book value is $32.32 million

    Retained earnings

    -$294.57M
    VERU annual retained earnings is -$294.57 million

    Working capital

    $23.36M
    VERU annual working capital is $23.36 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$21.68M
    VERU annual cash flow from operations is -$21.68 million

    Cash from operations 1-year change

    +75.36%
    VERU annual cash flow from operations is up +75.36% year-on-year

    Cash from investing

    $146.20K
    VERU annual cash flow from investing activities is $146.20 thousand

    Cash from investing 1-year change

    -97.69%
    VERU annual cash flow from investing activities is down -97.69% year-on-year

    Cash from financing

    $36.83M
    VERU annual cash flow from financing activities is $36.83 million

    Cash from financing 1-year change

    +231.35%
    VERU annual cash flow from financing activities is up +231.35% year-on-year

    CAPEX

    CAPEX

    $158.30K
    VERU annual capital expenditures is $158.30 thousand

    CAPEX 1-year change

    -76.22%
    VERU annual capital expenditures is down -76.22% year-on-year

    Free Cash Flow

    Free cash flow

    -$21.84M
    VERU annual free cash flow is -$21.84 million

    Free cash flow 1-year change

    +75.37%
    VERU annual free cash flow is up +75.37% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    34.67%
    VERU annual gross profit margin is 34.67%

    Operating margin

    -225.85%
    VERU annual operating profit margin is -225.85%

    Net margin

    -223.86%
    VERU annual net profit margin is -223.86%

    ROA & ROE

    ROA

    -68.45%
    VERU annual return on assets is -68.45%

    ROE

    -145.40%
    VERU annual return on equity is -145.40%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VERU price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VERU price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.77
    VERU price to book ratio is 2.77

    PB ratio Sector rank

    69.69%
    VERU price to book ratio is higher than 69.69% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    VERU price to sales ratio value is unknown

    PS ratio Sector rank

    -
    VERU price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $50.61M
    VERU enterprise value is $50.61 million

    Enterprise value Sector rank

    39.61%
    VERU enterprise value is higher than 39.61% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.30
    VERU EV/EBITDA is -1.30

    EV/EBITDA Sector rank

    40.49%
    VERU EV/EBITDA is higher than 40.49% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.97
    VERU annual current ratio is 2.97

    Quick ratio

    2.62
    VERU annual quick ratio is 2.62

    Leverage

    Debt to equity

    0.31
    VERU annual debt to equity ratio is 0.31

    Interest coverage ratio

    -60.03
    VERU annual interest coverage ratio is -60.03

    Risk & Stability

    Piotroski F-Score

    -
    VERU piotroski f-score value is unknown

    Altman Z-Score

    -6.50
    VERU altman z-score is -6.50

    Analyst ratings

    Recent major analysts updates

    Jan 2, 25 HC Wainwright & Co.
    Buy
    Dec 20, 24 HC Wainwright & Co.
    Buy
    Nov 5, 24 Oppenheimer
    Outperform
    May 14, 24 B. Riley Securities
    Buy
    May 13, 24 HC Wainwright & Co.
    Buy
    May 6, 24 HC Wainwright & Co.
    Buy
    Apr 15, 24 Oppenheimer
    Outperform
    Mar 28, 24 Raymond James
    Outperform
    Feb 8, 24 HC Wainwright & Co.
    Buy
    Sep 27, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with VERU included

    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Veru?
    • Does Veru pay dividends?
    • What sector is Veru in?
    • What industry is Veru in?
    • What country is Veru based in?
    • When did Veru go public?
    • Is Veru in the S&P 500?
    • Is Veru in the NASDAQ 100?
    • Is Veru in the Dow Jones?
    • When was Veru's last earnings report?
    • When does Veru report earnings?
    • Should I buy Veru stock now?

    What is the ticker symbol for Veru?

    The ticker symbol for Veru is NASDAQ:VERU

    Does Veru pay dividends?

    No, Veru does not pay dividends

    What sector is Veru in?

    Veru is in the Healthcare sector

    What industry is Veru in?

    Veru is in the Biotechnology industry

    What country is Veru based in?

    Veru is headquartered in United States

    When did Veru go public?

    Veru's initial public offering (IPO) was on February 11, 1999

    Is Veru in the S&P 500?

    No, Veru is not included in the S&P 500 index

    Is Veru in the NASDAQ 100?

    No, Veru is not included in the NASDAQ 100 index

    Is Veru in the Dow Jones?

    No, Veru is not included in the Dow Jones index

    When was Veru's last earnings report?

    Veru's most recent earnings report was on May 8, 2025

    When does Veru report earnings?

    The date for Veru's next earnings report has not been announced yet

    Should I buy Veru stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page